SPRINT-TB Director Prof. Nicholas Paton and SPRINT-TB Manager Dr. Kristina Rutkute were interviewed by Clearstate, the Economist Intelligence Unit, to share their opinion for a white paper on the Singapore biosciences landscape 2025. The white paper was commissioned by BioSingapore, an industry association for life sciences businesses in Singapore.
​
The white paper has elicited views from a broad group of industry and research participants, influencers and key opinion leaders about the future of the biosciences industry in Singapore. It assesses trends impacting the biosciences sector, Singapore’s position vis-à-vis regional clusters, and analyses how Singapore should grow industry capabilities in the future. The publication provides themes that can help to guide the development of innovative ideas to propel the next lap of Biosciences growth in Singapore. 

The white paper is available for download here.

Congratulations to Dr. Gail Cross, Clinical Research Fellow under SPRINT-TB Theme 3, for winning September 2015 Pitch for Funds Round with a project titled "Evaluating Whole Blood Bactericidal Activity of Bortezomib against Mycobacterium tuberculosis in Healthy Volunteers". The award, which amounts to SGD $10,000, will enable a clinical study testing bortezomib (compound discovered by Theme 1 as being effective against Mtb) in a whole blood bactericidal activity assay.

'Pitch for Funds' is an event organized by NUHS Clinician Scientist Unit to provide support to registrars and associate consultants conducting interdisciplinary research with collaborators from National University of Singapore Yong Loo Lin School of Medicine. In each competitive pitch round, taking place twice a year, two outstanding presentations selected by a review panel win the funding award.